ERBB2 and neoplasm: In particular, dysregulation of tyrosine kinase receptors, such as epidermal growth factor receptor 1 (ERBB1/EGFR) and epidermal growth factor receptor 2 (ERBB2/ErbB2) activates key signaling pathways involved in tumor cell proliferation and metastasis [13, 14].